Dulski J, Al-Shaikh RH, Sulek A, Kasprzak J, Sławek J, Wszolek ZK. Spinocerebellar ataxia type 3 (Machado-Joseph disease). Pol Arch Intern Med. 2022;132(10):16322. https://doi.org/10.20452/pamw.16322.

Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):24.

Article  PubMed  Google Scholar 

Rüb U, Brunt ER, de Vos RA, Del Turco D, Del Tredici K, Gierga K, Schultz C, Ghebremedhin E, Bürk K, Auburger G, et al. Degeneration of the central vestibular system in spinocerebellar ataxia type 3 (SCA3) patients and its possible clinical significance. Neuropathol Appl Neurobiol. 2004;30(4):402–14.

Article  PubMed  Google Scholar 

Paulino R, Nóbrega C. Autophagy in spinocerebellar ataxia type 3: from pathogenesis to therapeutics. Int J Mol Sci. 2023;24(8):7405. https://doi.org/10.3390/ijms24087405.

Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handb Clin Neurol. 2012;103:227–51.

Article  PubMed  Google Scholar 

Hersheson J, Haworth A, Houlden H. The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum Mutat. 2012;33(9):1324–32.

Article  CAS  PubMed  Google Scholar 

Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174–83.

Article  PubMed  Google Scholar 

Matos CA, de Almeida LP, Nóbrega C. Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy. J Neurochem. 2019;148(1):8–28.

Article  CAS  PubMed  Google Scholar 

Zesiewicz TA, Greenstein PE, Sullivan KL, Wecker L, Miller A, Jahan I, Chen R, Perlman SL. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology. 2012;78(8):545–50.

Article  CAS  PubMed  Google Scholar 

Coarelli G, Heinzmann A, Ewenczyk C, Fischer C, Chupin M, Monin ML, Hurmic H, Calvas F, Calvas P, Goizet C, et al. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2022;21(3):225–33.

Article  CAS  PubMed  Google Scholar 

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, et al. Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology. Neurology. 2018;90(10):464–71.

Article  PubMed  PubMed Central  Google Scholar 

McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, Krystal AD, Sampson SM, Morales O, Nelson BG, Latoussakis V, George MS, Lisanby SH; National Network of Depression Centers rTMS Task Group; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry. 2018;79(1):16cs10905. https://doi.org/10.4088/JCP.16cs10905.

Konstantinou G, Hui J, Ortiz A, Kaster TS, Downar J, Blumberger DM, Daskalakis ZJ. Repetitive transcranial magnetic stimulation (rTMS) in bipolar disorder: a systematic review. Bipolar Disord. 2022;24(1):10–26.

Article  PubMed  Google Scholar 

Li R, He Y, Qin W, Zhang Z, Su J, Guan Q, Chen Y, Jin L. Effects of repetitive transcranial magnetic stimulation on motor symptoms in parkinson’s disease: a meta-analysis. Neurorehabil Neural Repair. 2022;36(7):395–404.

Article  PubMed  Google Scholar 

Kumar S, Kalita J, Misra UK. Repetitive transcranial magnetic stimulation in cluster headache. Brain Stimul. 2019;12(2):383–4.

Article  PubMed  Google Scholar 

Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipović SR, Grefkes C, Hasan A, Hummel FC, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol. 2020;131(2):474–528.

Article  PubMed  Google Scholar 

Hu Z, Tao X, Huang Z, Xie K, Zhu S, Weng X, Lin D, Zhang Y, Wang L. Efficacy of high-frequency repetitive transcranial magnetic stimulation in a family with spinocerebellar ataxia type 3: a case report. Heliyon. 2023;9(5):e16190.

Article  PubMed  PubMed Central  Google Scholar 

Shiga Y, Tsuda T, Itoyama Y, Shimizu H, Miyazawa KI, Jin K, Yamazaki T. Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry. 2002;72(1):124–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimizu H, Tsuda T, Shiga Y, Miyazawa K, Onodera Y, Matsuzaki M, Nakashima I, Furukawa K, Aoki M, Kato H, et al. Therapeutic efficacy of transcranial magnetic stimulation for hereditary spinocerebellar degeneration. Tohoku J Exp Med. 1999;189(3):203–11.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Salcı Y, Fil A, Keklicek H, Çetin B, Armutlu K, Dolgun A, Tuncer A, Karabudak R. Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia. Mult Scler Relat Disord. 2017;18:135–40.

Article  PubMed  Google Scholar 

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.

Article  PubMed  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

Article  PubMed  Google Scholar 

Sikandar A, Liu XH, Xu HL, Li Y, Lin YQ, Chen XY, Li GH, Lin MT, Wang N, Chen WJ, et al. Short-term efficacy of repetitive transcranial magnetic stimulation in SCA3: a prospective, randomized, double-blind, sham-controlled study. Parkinsonism Relat Disord. 2023;106:105236.

Article  CAS  PubMed  Google Scholar 

Manor B, Greenstein PE, Davila-Perez P, Wakefield S, Zhou J, Pascual-Leone A. Repetitive transcranial magnetic stimulation in spinocerebellar ataxia: a pilot randomized controlled trial. Front Neurol. 2019;10:73.

Article  PubMed  PubMed Central  Google Scholar 

Chen XY, Lian YH, Liu XH, Sikandar A, Li MC, Xu HL, Hu JP, Chen QL, Gan SR. Effects of repetitive transcranial magnetic stimulation on cerebellar metabolism in patients with spinocerebellar ataxia type 3. Front Aging Neurosci. 2022;14:827993.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Y, Zou G, Chen Z, Wan L, Peng L, Peng H, Shen L, Xia K, Qiu R, Tang B, Jiang H. Efficacy of cerebellar transcranial magnetic stimulation in spinocerebellar ataxia type 3: a randomized, single-blinded, controlled trial. J Neurol. 2023;270(11):5372–9. https://doi.org/10.1007/s00415-023-11848-2.

França C, de Andrade DC, Silva V, Galhardoni R, Barbosa ER, Teixeira MJ, Cury RG. Effects of cerebellar transcranial magnetic stimulation on ataxias: a randomized trial. Parkinsonism Relat Disord. 2020;80:1–6.

Article  PubMed  Google Scholar 

Zhou M, Qiu M, Jin Y, Li D, Tao C, Lou D, Hu Z, Wang Y, You Z, Shao Y, Zhu Y, Qu M, Lu X. Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with spinocerebellar ataxia type 3. J Ect. 2023. https://doi.org/10.1097/YCT.0000000000000925.

Maas R, van de Warrenburg BPC. Exploring the clinical meaningfulness of the scale for the assessment and rating of ataxia: a comparison of patient and physician perspectives at the item level. Parkinsonism Relat Disord. 2021;91:37–41.

Article  PubMed  Google Scholar 

Bai G, Jiang L, Huan S, Meng P, Wang Y, Pan X, Yin S, Zhao Y, Wang Q. Study on low-frequency repetitive transcranial magnetic stimulation improves speech function and mechanism in patients with non-fluent aphasia after stroke. Front Aging Neurosci. 2022;14: 883542.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirano T. Long-term depression and other synaptic plasticity in the cerebellum. Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(5):183–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang DJ, Su LD, Wang YN, Yang D, Sun CL, Zhou L, Wang XX, Shen Y. Long-term potentiation at cerebellar parallel fiber-Purkinje cell synapses requires presynaptic and postsynaptic signaling cascades. J Neurosci. 2014;34(6):2355–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232(2):331–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fierro B, Giglia G, Palermo A, Pecoraro C, Scalia S, Brighina F. Modulatory effects of 1 Hz rTMS over the cerebellum on motor cortex excitability. Exp Brain Res. 2007;176(3):440–7.

Article  PubMed  Google Scholar 

Morellini N, Grehl S, Tang A, Rodger J, Mariani J, Lohof AM, Sherrard RM. What does low-intensity rTMS do to the cerebellum? Cerebellum. 2015;14(1):23–6.

Article  CAS  PubMed  Google Scholar 

Popa T, Russo M, Meunier S. Long-lasting inhibition of cerebellar output. Brain Stimul. 2010;3(3):161–9.

Article  CAS  PubMed  Google Scholar 

Fernandez L, Major BP, Teo WP, Byrne LK, Enticott PG. Assessing cerebellar brain inhibition (CBI) via transcranial magnetic stimulation (TMS): a systematic review. Neurosci Biobehav Rev. 2018;86:176